Поисковый запрос: (<.>S=ПРОТЕИНКИНАЗЫ ИНГИБИТОРЫ<.>) |
Общее количество найденных документов : 57
Показаны документы с 1 по 20
|
|
1.
| 3-Amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38'альфа' mitogen-activated protein kinase // J. Med. Chem., 2008. Vol. 51, N 20.-С.6280-6292
|
2.
| A p38'альфа' selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss // J. Pharmacol. and Exp. Ther., 2007. Vol. 320, N 1.-С.56-63
|
3.
| Advances in kinase targeting: current clinical use and clinical trials // Trends Pharmacol. Sci., 2014. Vol. 35, N 11.-С.604-620
|
4.
| Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of I'каппа'B kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation // J. Pharmacol. and Exp. Ther., 2005. Vol. 312, N 1.-С.373-381
|
5.
| Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of I'каппа'B kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation // J. Pharmacol. and Exp. Ther., 2005. Vol. 312, N 1.-С.373-381
|
6.
| Baskys Neuroprotective effects of mitogen-activated protein kinase (MAPK) cascade inhibitors
|
7.
| Baskys Neuroprotective effects of mitogen-activated protein kinase (MAPK) cascade inhibitors
|
8.
| Benzazole derivatives and their use as JNK modulators
|
9.
| Ca{2+}/calmodulin-dependent protein kinase II inhibitors potentiate superoxide production in polymorphonuclear leukocytes // J. Pharm. and Pharmacol., 1999. Vol. 51, N 3.-С.295-300
|
10.
| Chatterjee Tapan K. Ca{2}+-dependent, ATP-induced conversion of the [{3}H]Hemicholinium-3 binding sites from high- to lowaffinity states in rat striatum: Effect of protein kinase inhibitors on this affinity conversion and synaptosomal choline transport // J. Neurochem., 1990. Vol. 54, N 5.-С.1500-1508
|
11.
| Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney mode // Drug Dev. and Ind. Pharm., 2010. Vol. 36, N 3.-С.315-322
|
12.
| Cytoplasmic desmosome formation by H-7 and EGF treatment in cultured fetal rat keratinocytes // Tissue and Cell, 1996. Vol. 28, N 5.-С.537-545
|
13.
| Cytoplasmic desmosome formation by H-7 and EGF treatment in cultured fetal rat keratinocytes // Tissue and Cell, 1996. Vol. 28, N 5.-С.537-545
|
14.
| Discovery and optimization of p38 inhibitors via computer-assisted drug design // J. Med. Chem., 2007. Vol. 50, N 17.-С.4016-4026
|
15.
| Discovery of TAK-960: An orally available small molecule inhibitor of polo-like kinase 1 (PLK1) // Bioorg. and Med. Chem. Lett., 2013. Vol. 23, N 12.-С.3662-3666
|
16.
| Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells // Biol. and Pharm. Bull., 2008. Vol. 31, N 9.-С.1716-1722
|
17.
| Effects of genistein and staurosporine on agiotensin II-induced DNA synthesis, protein synthesis and mitogen-activated protein kinase activation in vascular smooth muscle cells // Biol. and Pharm. Bull., 1998. Vol. 21, N 10.-С.1045-1049
|
18.
| Effects of HA 1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle // Eur. J. Pharmacol., 1991. Vol. 195, N 2.-С.267-272
|
19.
| Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic ras // J. Pharmacol. and Exp. Ther., 2008. Vol. 326, N 1.-С.41-50
|
20.
| Hidaka Pharmacology of protein kinase inhibitors // Annu. Rev. Pharmacol. and Toxicol.. -Palo Alto (Calif.), 1992, Vol. 32.-С.377-397
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"